Photo AI

Evaluate one treatment for schizophrenia that you have studied. - AQA - A-Level Psychology - Question 4 - 2018 - Paper 2

Question icon

Question 4

Evaluate-one-treatment-for-schizophrenia-that-you-have-studied.-AQA-A-Level Psychology-Question 4-2018-Paper 2.png

Evaluate one treatment for schizophrenia that you have studied.

Worked Solution & Example Answer:Evaluate one treatment for schizophrenia that you have studied. - AQA - A-Level Psychology - Question 4 - 2018 - Paper 2

Step 1

Evaluate one treatment for schizophrenia that you have studied.

96%

114 rated

Answer

One widely studied treatment for schizophrenia is the use of anti-psychotic drugs.

Description of Anti-Psychotics

Anti-psychotic medications are designed to change the chemistry in the brain. They primarily work by blocking dopamine receptors, thereby minimizing the effects of dopamine, which is often overactive in individuals with schizophrenia.

Patients can take these anti-psychotic medications in various forms, including syrups or tablets. In cases where patients have difficulty swallowing pills, liquid forms may be preferred. It is essential for medical practitioners to articulate the importance of adherence to medication, as some patients may be reluctant to take their prescribed anti-psychotics.

Effectiveness and Compliance

Research shows that anti-psychotic drugs have a strong efficacy rate. For instance, Emsley (2008) found that 84% of patients on anti-psychotics experienced at least a 50% reduction in their symptoms when given adequate dosages. Furthermore, anti-psychotics can help patients socialize and reintegrate into society, as they often allow individuals to function better than they would without treatment.

Challenges with Treatment

However, there exist challenges with anti-psychotic treatments. Some patients may refuse to take these medications due to concerns about side effects or a lack of insight into their condition. Studies, such as those by Rosa et al. (2005), indicate that only 50% of patients regularly complied with their medication regimen. This reluctance can hinder the treatment process and contribute to the potential for relapse.

Conclusion

Overall, while anti-psychotic medications are a cornerstone in treating schizophrenia, patient adherence remains a significant issue. Addressing the barriers to compliance, such as educating patients about the importance of their medications and managing side effects, is vital for the success of this treatment.

Join the A-Level students using SimpleStudy...

97% of Students

Report Improved Results

98% of Students

Recommend to friends

100,000+

Students Supported

1 Million+

Questions answered

;